Fintepla — United Healthcare
seizure disorder (continuation of prior therapy)
Initial criteria
- Diagnosis of Lennox-Gastaut syndrome or Dravet syndrome OR continuation of prior therapy for a seizure disorder
Reauthorization criteria
- Documentation of positive clinical response to therapy
Approval duration
12 months